Letermovir vs Valganciclovir in CMV R+ Kidney Transplant

Clinical trial NCT07571135 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07571135
Sponsor: Elisabeth Kincaide
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

CMV Infection CMV CMV Viremia CMV Disease

Start date: 2026-05-01
Primary completion: 2028-11-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.